We assessed the impact of operator expertise on collection of the APACHE II score, the derived risk of death and standardized mortality ratio in 465 consecutive patients admitted to a multi-disciplinary tertiary hospital ICU. Research coordinators and junior clinical staff independently collected the APACHE II variables; experts (senior clinical staff) rescored 20 % of the records. Agreement was moderate between junior clinical staff and research coordinators or senior clinical staff for most variables of the acute physiology score (weighted k<0.6); agreement between research coordinators and senior clinical staff data collectors was good (weighted k >0.75). The APACHE II score and its derived risk of death (ROD) were significantly lower using the junior clinical staff dataset compared to research coordinators and senior clinical staff (APACHE II score: 13.4±9.2 vs 16.8±8.5 vs 17.1±7.7, P<0.001; ROD: 14.7%±22.4% vs 21.6%±22.6% vs 20.8%±22.4%, P<0.01 respectively). The discriminative capacity was not altered by the lack of agreement (area under Receiver Operator Characteristic curve >0.8) but calibration of ROD from the junior clinical staff dataset was poor (Goodness-of-fit: P=0.001). The standardized mortality ratio (SMR) was higher with the junior clinical staff dataset (SMR: 1.22, 95% CI: 0.96-1.52 vs 0.87, 95% CI: 0.70-1.06 vs 0.76, 95% CI: 0.40-1.3 calculated from junior clinical staff, research coordinators and senior clinical staff datasets respectively). We conclude that the expertise of data collectors significantly influences the APACHE II score, the derived risk of death and the standardized mortality ratio. Given the importance of such scores, ICUs should be provided with sufficient resources to train and employ dedicated data collectors.
Despite the advent of more recent severity scoring systems such as The Simplified Acute Physiology Score (SAPS) II 1 and the Acute Physiology And Chronic Health Evaluation III (APACHE III) score 2 , the Acute Physiology And Chronic Health Evaluation II (APACHE II) score 3 remains one of the most widely used severity scoring systems in intensive care practice. In addition, it is frequently used to characterize baseline severity of illness in clinical trials. Of six recent high-profile trials in critically ill patients (The Transfusion requirements in critical care trial 4 , The PROWESS Study of activated Protein C in severe sepsis 5 , Van den Berghe and colleagues' Intensive Insulin Therapy Study 6 , Annane and colleagues' trial of steroids for septic shock 7 , Early goal directed therapy in septic shock 8 , The SAFE Study 9 ), four used APACHE II alone [4] [5] [6] 9 , one used APACHE II and SAPS II Score 8 , only one used SAPS II alone 7 . A more recent development has been the use of the APACHE II score to determine whether individual patients should be treated with drotrecogin alfa (activated) 10 .
The ability of the APACHE II score to predict patients' outcome has been extensively evaluated [11] [12] [13] [14] [15] [16] [17] [18] ; these studies showed that the APACHE II score has a good discrimination power but its calibration was poor in all studies except one 17 . Its use to compare intensive care unit performance 19 or to assess the efficacy of new treatment 20 is less well validated. The APACHE II score was designed to assess populations and use of a derived algorithm to predict individual patient outcome remains highly controversial 21, 22 . Although a number of studies have examined the usefulness or validity of the APACHE II score in various settings, assessment of data collection quality is frequently missing in such studies. Only a few papers have considered the impact of inter-observer correlation on the reliability of scoring systems. Holt et al reported that although inter-observer variability had minimal impact on predicted mortality among a large population of patients the impact on individual prediction was significant 23 . More recent studies have drawn opposing conclusions. Goldhill and colleagues concluded that the potential differences in severity scores due to data collection are sufficient to alter considerably the average predicted mortality and mortality ratio 24 . Polderman and co-workers also observed a wide variability of APACHE II score in individuals when APACHE II variables were recorded by junior clinical staff or senior clinical staff 25 . In a study where all data collectors attended a one-day training session, Chen and co-workers found no significant effect of variability in data collection from different hospitals 26 . Polderman et al found that following a training guideline could markedly decrease inter-observer variability in APACHE II scoring 27 .
Collectively these studies suggest that training in data collection plays a significant role in the accuracy of derived severity of illness scores and that it merits considerable attention. However, data collection may sometimes be given a low priority and delegated to more junior members of the medical team. The aim of the present study was to assess the impact of data collection expertise on the accuracy of data collected to derive the APACHE II score in a level III tertiary hospital ICU in Sydney and to evaluate the influence that data variability may have on APACHE II scoring and on derived prediction of mortality.
MATERIALS AND METHODS
The study was conducted in the Intensive Care Unit at the Royal North Shore Hospital in Sydney, Australia. The ICU is a 29-bed level III unit in a metropolitan, tertiary, university-affiliated hospital. Data were analysed on all consecutive admissions over a seven-month period. As in the original APACHE II study 3 , patients under 16 years of age, those admitted after cardiac surgery and for the treatment of burns were excluded from the analysis. The institutional human research ethics committee waived the need for informed consent because no patient intervention was required and patient anonymity was preserved.
Data collection, computer entry and processing
For each patient, two groups of data collectors gathered data. One group was composed by two registered nurse research coordinators with previous experience of collecting the APACHE II score, who received detailed training, and a written procedures manual documenting how the scores should be collected (research coordinator group). The second group consisted of 12 ICU residents working an alternating week-on, week-off roster of 12-hour day and night shifts. These residents, who had no previous experience in collecting the APACHE II score, were given informal ward-based training on data collection (junior clinical staff group). Both groups collected data prospectively and independently. Of the 465 scores included in the study, 100 (21.5%) were randomly selected and rescored retrospectively from the medical record by two of the authors (DL, SF) (senior clinical staff group). The senior clinical staff has extensive experience in collecting the APACHE II score with access to the original data collection instructions from Knaus' study 3 and a research interest in the question being answered. Data were collected on paper forms and then encoded on three separated databases and imported into a spreadsheet for data analysis.
The APACHE II score and its derived risk of death were calculated, using the same software for all groups, using the published equation and coefficient 3 .
Data analysis
Comparisons for inter-observer assessment were made on points attributed by the APACHE II score for each physiological variables, age and chronic health status. For these data, the weighted kappa test and inter-observer agreement were calculated. The kappa was interpreted as follow: k<0.20 poor agreement, k=0.21 to 0.4 fair agreement, k=0.41 to 0.6 moderate agreement, k=0.61 to 0.8 good agreement, k=0.81 to 1.0 very good agreement 28 . The intraclass correlation coefficient was calculated to assess the agreement of the APACHE II score. An intraclass correlation coefficient of 0.75 or better was considered excellent reproducibility, a coefficient between 0.4 and 0.75 was considered fair to good reproducibility and a coefficient below 0.4 was considered poor reproducibility 29 . The ANOVA for repeated measures was used to compare APACHE II score and its derived Risk of Death (ROD) obtained from each data set, differences were considered statistically significant if the P value was below 0.05. The 95% confidence interval of the standardized mortality ratio (SMR) was estimated by the exact Poisson confidence interval 30 .
RESULTS
Over a seven-month period, from May 1994 to November 1994, the data to derive APACHE II scores were collected for 465 patients by the junior clinical staff and research coordinator groups. The senior clinical staff group reabstracted one hundred patients; complete data were available for 83 of these patients (18% of the initial dataset). The agreement rate and kappa test for the physiologic points assigned by the Acute Physiologic and Chronic Health Evaluation (APACHE) II score from the three datasets are summarized in Table 1 . For the Acute Physiology Score (APS), the kappa statistic ranged from 0.35 to 0.59 for the comparison between the junior clinical staff and research coordinator datasets, from 0.34 to 0.68 for the comparison between the junior clinical staff and senior clinical staff datasets and from 0.54 to 0.91 for the comparison between the research coordinator and senior clinical staff datasets. The comparison of junior clinical staff with research coordinator datasets showed that the agreement was moderate for the 12 APS variables (kappa <0.6). The observation was similar for the comparison between junior clinical staff and senior clinical staff datasets where only two components had a good agreement (creatinine, k=0.68 and WBC, k=0.68). The com-parison between research coordinator and senior clinical staff datasets showed that the agreement was good to excellent for 11 of the twelve components. The Glasgow coma score (GCS) was the only variable with a moderate agreement (k=0.54). Agreement for the determination of chronic health disease, emergency surgery status and principal diagnostic category as defined in the first description of the APACHE II score 3 was poor within all data sets. The overall agreement of the APACHE II assessed by the intraclass correlation coefficient (ICC) was moderate between junior clinical staff versus research coordinator (ICC=0.67, 95% C.I.: 0.43-0.79) and good between junior clinical staff versus senior clinical staff (ICC=0.72, 95% C.I.: 0.39-0.84). The APACHE II score agreement was excellent between research coordinator and senior clinical staff (ICC=0.81, 95% C.I.: 0.71-0.87). The APACHE II score and its derived risk of death were significantly lower when calculated from the junior clinical staff dataset compared to other datasets ( Table  2 ). The area under the ROC curve for the risk of death to predict outcome were similar for the three data sets, however the Hosmer-Lemeshow goodness-of-fit test showed a low P value in the junior clinical staff data set (P=0.001) indicating poor calibration of the scoring system. Conversely, the P values were greater than 0.05 when the Hosmer-Lemeshow goodnessof-fit test was performed on research coordinator and senior clinical staff data sets demonstrating good calibration of the risk of death ( Table 3 ). The standardized mortality ratio (SMR) calculated from risk of death obtained with each dataset are shown in Figure 1 . The observed mortality was higher than expected when the SMR was calculated with the junior clinical staff dataset (SMR=1.22; 95% CI, 0.96-1.52) whereas mortality was lower than expected when the SMR was calculated from the research coordinator or senior clinical staff dataset (research coordinator: SMR=0.87; 95% CI, 0.70-1.06; senior clinical staff: SMR=0.76; 95% CI, 0.40-1.30).
DISCUSSION
In this study, we found that the level of expertise of data collectors had a significant effect on the data collected to calculate the APACHE II score and this in turn influenced the derived risk of death and standardized mortality ratio estimates. The junior clinical staff appeared to be less reliable. Their agreement with research coordinator and senior clinical staff groups was poor for almost all the variables from the Acute Physiology Score. The observed inaccuracy led to a lack of overall agreement between the junior clinical staff group and other groups for the APACHE II score and its derived risk of death. The poor agreement of the APACHE II score did not alter its discriminating power, which was good for all groups as shown by an area under the ROC curve above 0.8. However, its calibration was affected by the quality of data collection; the goodness-of-fit test showed poor calibration for risk of death calculated from the junior clinical staff group. The agreement for disease diagnosis-i.e. chronic health disease, emergency surgery status and principal diagnostic category-was poor between each pair of groups.
Junior clinical staff and research coordinator completed the data collection prospectively; the senior clinical staff group reabstracted the data retrospectively. This led to an increased rate of missing data (83% of the reabstracted patients had complete data). However as our protocol was designed to review 20% of the patients prospectively included, the senior clinical staff dataset was large enough to allow suitable statistical analysis.
Comparisons of the APACHE II score variables collected by different observers are scarce in the literature. The originality of the present study was to assess junior clinical staff and research coordinator data collectors prospectively in a real life situation as the data collectors were not aware of the interobserver evaluation. To our knowledge only one study has compared junior clinical staff with senior clinical staff 25 : in that study the authors observed that there was a great variability in individual patients, however inter-observer correlation of the APACHE II score variables was not reported. The good to excellent agreement between research coordinator and senior clinical staff has been reported in previous studies 23, 26, 27, 31 and our results support these findings. However, in common with other authors we found agreement in scoring the GCS to be poor regardless of the expertise of the data collectors.
Our results suggest that the APACHE II score and its derived risk of death are materially affected by the level of expertise of those collecting the data. In our study, the mean APACHE II score and the mean risk of death were significantly lower when calculated from the junior clinical staff dataset. Goldhill et al made a similar observation 24 . They found that rescoring APACHE II looking at the strict interpretation of the APACHE II criteria led to a 1.73 points mean increase in the APACHE II score resulting in a 3% increase in predicted mortality. In contrast, Chen et al observed that although there were significant discrepancies in some of its components, the APACHE II score was not affected 26 . Polderman et al found that once reabstracted the mean APACHE II score was 3.9 points lower than the original 32 . The observed differences in the APACHE II score did not significantly influence the discrimination power of the APACHE II score as shown by the area under the ROC curve. However, the calibration was poor when the APACHE II score was calculated from the junior clinical staff dataset and this affected the reliability of the score for risk stratification. Moreover, the inaccuracy of the APACHE II score risk of death led to differences in the standardized mortality ratio (SMR), which was higher when calculated from the junior clinical staff dataset. The SMR derived from the APACHE II score has been proposed as a tool for assessing ICU quality of care 19, 33, 34 . This has been criticised by several authors [35] [36] [37] and our results support these criticisms. Depending on which dataset is used, the ICU where the study was conducted could be considered to have either low performance (SMR from junior clinical staff dataset=1.22) or high performance (SMR from research coordinator dataset=0.87). A computerized patient data management system (PDMS) or clinical information system (CIS) was not in use in the ICU where the study was conducted. ICUs that use such a computerized system might have a different experience with collecting the APACHE II score.
In common with other authors 26 we found that determining a correct diagnosis on admission and correct chronic health scores is challenging. The reason might be the poor definition of diagnosis in the APACHE II system but also the lack of clarity in the patients' charts.
Like others, we found that the three items with poorer reliability were GCS, chronic health condition and the primary diagnosis. New scoring systems should focus on improving the definitions of chronic health conditions and ICU admission diagnoses. In new severity scores neurological assessment could be better achieved by using the motor component of GCS instead of the aggregate GCS 38 .
In conclusion, our study confirms that the expertise of data collectors influences inter-observer agreement of APACHE II scoring and illustrates that great caution is required when using severity scores to compare the performance of ICUs. The use of APACHE II score for risk stratification-in clinical trials for example-requires proper training of data collectors and appropriate data quality checks. The Food and Drug Administration recommends the use of the APACHE II score to screen patients who would most probably benefit from treatment with drotrecogin alfa activated 10 . However, given the results of our study, the use of the APACHE II score to determine the prescription of new and expensive therapies in the ICU needs to be approached with caution. Our study demonstrates that using untrained data collectors to determine the APACHE II score could deny treatment to a number of patients who would benefit from such treatments. Our results suggest that the scores used for such purpose should be collected by staff with training and experience in determining the APACHE II score.
The APACHE II score has now been in use in clinical and research practice for 20 years and so has proven its durability. The results of our study demonstrate the importance of strict guidelines and proper training to ensure that data collection is accurate. Given the importance of collecting such data and the worldwide drive to improve quality and safety in healthcare, all ICUs should be allocated appropriate resources to train and employ dedicated data collectors.
